Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
Clinical trial NCT05439278 · RECRUITING
Trial details
- NCT number
- NCT05439278
- Sponsor
- Severance Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2028-12-31
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.